• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

呼吸道合胞病毒感染住院的五岁以下儿童的发病率、危险因素及医院负担

Incidence, risk factors and hospital burden in children under five years of age hospitalised with respiratory syncytial virus infections.

作者信息

Svensson Charlotta, Berg Karin, Sigurs Nele, Trollfors Birger

机构信息

Department of Paediatrics, Angered Hospital, Gothenburg, Sweden.

North Älvsborg Hospital, Trollhättan, Sweden.

出版信息

Acta Paediatr. 2015 Sep;104(9):922-6. doi: 10.1111/apa.13061. Epub 2015 Jul 2.

DOI:10.1111/apa.13061
PMID:26036725
Abstract

AIM

Respiratory syncytial virus (RSV) infections are among the most common lower respiratory tract infections in infants, but few studies have determined the age-specific incidence of hospitalisation in defined populations. This study gathered Swedish data on RSV in Gothenburg and its 10 surrounding municipalities from 2004 to 2011.

METHODS

Information was obtained from hospital databases of all patients up to five years of age who had a discharge diagnosis of an RSV infection and had a positive antigen detection or polymerase chain reaction test.

RESULTS

A total of 1764 children fulfilled the inclusion criteria and 238 of these were preterm. The incidence under one year of age was 17.4/1000/year, and in children aged one to four years it was 0.6/1000/year. RSV patients occupied a mean of 1141 hospital beds per year: 65 were treated in the intensive care unit, 27 needed ventilator support, 19 needed continuous positive airway pressure, 408 (23%) received antibiotics, 399 (23%) received steroids, and all but four patients received a bronchodilator. All children survived.

CONCLUSION

The incidence of RSV infections was high, medication use was high, and complications were low. Preterm infants had a higher risk, but most infants needing hospitalisation for RSV are full term and have no known risk factors.

摘要

目的

呼吸道合胞病毒(RSV)感染是婴儿最常见的下呼吸道感染之一,但很少有研究确定特定人群中按年龄划分的住院发病率。本研究收集了2004年至2011年瑞典哥德堡及其周边10个城市关于RSV的相关数据。

方法

从所有5岁以下出院诊断为RSV感染且抗原检测或聚合酶链反应试验呈阳性的患者的医院数据库中获取信息。

结果

共有1764名儿童符合纳入标准,其中238名是早产儿。1岁以下儿童的发病率为每年17.4/1000,1至4岁儿童的发病率为每年0.6/1000。RSV患者每年平均占用1141张医院床位:65名在重症监护室接受治疗,27名需要呼吸机支持,19名需要持续气道正压通气,408名(23%)接受了抗生素治疗,399名(23%)接受了类固醇治疗,除4名患者外,所有患者均接受了支气管扩张剂治疗。所有儿童均存活。

结论

RSV感染发病率高,用药率高,并发症发生率低。早产儿风险较高,但大多数因RSV需要住院治疗的婴儿是足月儿,且无已知风险因素。

相似文献

1
Incidence, risk factors and hospital burden in children under five years of age hospitalised with respiratory syncytial virus infections.呼吸道合胞病毒感染住院的五岁以下儿童的发病率、危险因素及医院负担
Acta Paediatr. 2015 Sep;104(9):922-6. doi: 10.1111/apa.13061. Epub 2015 Jul 2.
2
Survey of pediatric ward hospitalization due to respiratory syncytial virus infection after the introduction of palivizumab to high-risk infants in Japan.在日本对高危婴儿引入帕利珠单抗后呼吸道合胞病毒感染导致的儿科病房住院情况调查。
Pediatr Int. 2011 Jun;53(3):368-73. doi: 10.1111/j.1442-200X.2010.03249.x.
3
Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group.帕利珠单抗是一种人源化呼吸道合胞病毒单克隆抗体,可降低高危婴儿因呼吸道合胞病毒感染而住院的几率。IMpact-RSV研究小组。
Pediatrics. 1998 Sep;102(3 Pt 1):531-7.
4
Epidemiology of respiratory syncytial virus infection in infants born at less than thirty-five weeks of gestational age.小于三十五孕周出生婴儿的呼吸道合胞病毒感染的流行病学。
Pediatr Infect Dis J. 2012 Aug;31(8):e99-104. doi: 10.1097/INF.0b013e318257f619.
5
Decline in respiratory syncytial virus hospitalizations in a region with high hospitalization rates and prolonged season.在住院率高且季节延长的地区,呼吸道合胞病毒住院人数下降。
Pediatr Infect Dis J. 2006 Dec;25(12):1116-22. doi: 10.1097/01.inf.0000245104.26996.57.
6
Palivizumab prophylaxis of respiratory syncytial virus disease from 1998 to 2002: results from four years of palivizumab usage.1998年至2002年帕利珠单抗预防呼吸道合胞病毒疾病:四年使用帕利珠单抗的结果
Pediatr Infect Dis J. 2003 Feb;22(2 Suppl):S46-54. doi: 10.1097/01.inf.0000053885.34703.84.
7
Effect of palivizumab prophylaxis in decreasing respiratory syncytial virus hospitalizations in premature infants.帕利珠单抗预防对降低早产儿呼吸道合胞病毒住院率的影响。
Pediatr Infect Dis J. 2003 Sep;22(9):823-7. doi: 10.1097/01.inf.0000086403.50417.7c.
8
Hospital admission of high risk infants for respiratory syncytial virus infection: implications for palivizumab prophylaxis.高危婴儿因呼吸道合胞病毒感染入院:对帕利珠单抗预防的影响。
Arch Dis Child Fetal Neonatal Ed. 2005 Jan;90(1):F64-8. doi: 10.1136/adc.2003.029710.
9
Appropriate prophylaxis with restrictive palivizumab regimen in preterm children in Sweden.瑞典对早产儿采用适当的帕利珠单抗限制方案进行预防。
Acta Paediatr. 2004 Nov;93(11):1470-3. doi: 10.1080/08035250410023197.
10
Respiratory syncytial virus prophylaxis in Down syndrome: a prospective cohort study.唐氏综合征患者呼吸道合胞病毒预防:一项前瞻性队列研究。
Pediatrics. 2014 Jun;133(6):1031-7. doi: 10.1542/peds.2013-3916. Epub 2014 May 5.

引用本文的文献

1
Hospitalizations for respiratory syncytial virus (RSV) in Sicily from 2008 to 2021: clinical features and predictors of severity.2008年至2021年西西里岛呼吸道合胞病毒(RSV)住院情况:临床特征及严重程度预测因素
Ital J Pediatr. 2025 Jul 2;51(1):205. doi: 10.1186/s13052-025-01998-6.
2
[Epidemiological characteristics of respiratory syncytial virus infection in children in Nanchang and its correlation with climate environmental factors].[南昌地区儿童呼吸道合胞病毒感染的流行病学特征及其与气候环境因素的相关性]
Zhongguo Dang Dai Er Ke Za Zhi. 2024 Dec 15;26(12):1282-1287. doi: 10.7499/j.issn.1008-8830.2406109.
3
Interferon Epsilon-Mediated Antiviral Activity Against Human Metapneumovirus and Respiratory Syncytial Virus.
干扰素ε对人偏肺病毒和呼吸道合胞病毒的抗病毒活性
Vaccines (Basel). 2024 Oct 21;12(10):1198. doi: 10.3390/vaccines12101198.
4
Trends in hospitalizations of children with respiratory syncytial virus aged less than 1 year in Italy, from 2015 to 2019.意大利 2015 至 2019 年小于 1 岁因呼吸道合胞病毒住院的儿童趋势。
Ital J Pediatr. 2024 Jun 21;50(1):119. doi: 10.1186/s13052-024-01688-9.
5
Respiratory Syncytial Virus-Associated Hospitalizations in Children: A 10-Year Population-Based Analysis in Finland, 2008-2018.呼吸道合胞病毒相关儿童住院治疗:芬兰 2008-2018 年基于人群的 10 年分析。
Influenza Other Respir Viruses. 2024 Mar;18(3):e13268. doi: 10.1111/irv.13268.
6
Respiratory syncytial virus among hospitalized patients of severe acute respiratory infection in Bhutan: Cross-sectional study.不丹严重急性呼吸道感染住院患者中呼吸道合胞病毒:横断面研究。
Influenza Other Respir Viruses. 2024 Jan 17;18(1):e13242. doi: 10.1111/irv.13242. eCollection 2024 Jan.
7
Respiratory syncytial virus-associated hospitalization in children aged <2 years in Spain from 2018 to 2021.西班牙 2018 年至 2021 年 2 岁以下儿童因呼吸道合胞病毒感染而住院的情况。
Hum Vaccin Immunother. 2023 Aug 1;19(2):2231818. doi: 10.1080/21645515.2023.2231818. Epub 2023 Jul 12.
8
Respiratory syncytial virus-associated hospitalisation in children aged ≤5 years: a scoping review of literature from 2009 to 2021.5岁及以下儿童呼吸道合胞病毒相关住院情况:2009年至2021年文献的范围综述
ERJ Open Res. 2022 May 30;8(2). doi: 10.1183/23120541.00593-2021. eCollection 2022 Apr.
9
Hospital Contacts for Infectious Diseases Among Children in Denmark, Finland, Norway, and Sweden, 2008-2017.2008 - 2017年丹麦、芬兰、挪威和瑞典儿童传染病的医院接触情况
Clin Epidemiol. 2022 Apr 29;14:609-621. doi: 10.2147/CLEP.S355193. eCollection 2022.
10
Clinical Burden of Respiratory Syncytial Virus in Hospitalized Children Aged ≤5 Years (INSPIRE Study).住院≤5 岁儿童呼吸道合胞病毒的临床负担(INSPIRE 研究)。
J Infect Dis. 2022 Aug 26;226(3):386-395. doi: 10.1093/infdis/jiac137.